Document Detail


Comparison of effects of angiotensin II receptor blocker on morning home blood pressure and cardiorenal protection between morning administration and evening administration in hypertensive patients: the COMPATIBLE study.
MedLine Citation:
PMID:  23013888     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Whether the time of administering the angiotensin receptor antagonist olmesartan influences antihypertensive and renoprotective effectiveness remains unclear. This study compared the effects of olmesartan on morning home blood pressure (MHBP), office BP (OBP) and renoprotective parameters between morning and evening administration. A total of 218 patients with primary hypertension were randomly assigned to receive olmesartan once daily in the morning (morning-dose group) or evening (evening-dose group), and 188 completed the study protocol (morning-dose group, n=95; evening-dose group, n=93). In both groups, morning home systolic BP, morning home diastolic BP, office systolic BP and office diastolic BP decreased significantly. There was no significant difference between the groups in MHBP or OBP after 6 months of treatment. The urinary albumin-to-creatinine ratio (UACR) decreased from 13.9 to 6.9 mg g(-1) (geometric means, P<0.001) in the morning-dose group and from 14.4 to 9.1 mg g(-1) (P<0.001) in the evening-dose group. The changes in UACR after treatment did not differ significantly between the groups. SV(1)+RV(5) decreased significantly from baseline to 6 months in the morning-dose group (P<0.001) and the evening-dose group (P<0.01), and did not differ significantly between the groups. In conclusion, olmesartan effectively decreased MHBP, OBP, SV(1)+RV(5) and UACR regardless of whether the drug was administered in the morning or in the evening. Our results suggest that olmesartan can be prescribed once daily, either in the morning or in the evening.Hypertension Research advance online publication, 27 September 2012; doi:10.1038/hr.2012.142.
Authors:
Hisao Mori; Hareaki Yamamoto; Hiroshi Ukai; Shouhei Yuasa; Kazumi Nakajima; Takehiko Mikawa; Masamichi Niizuma; Kouichi Hirao; Satoshi Umemura
Related Documents :
23135868 - Aliskiren reduces home blood pressure and albuminuria in patients with hypertensive nep...
2440108 - The role of radiotherapy for epidemic kaposi's sarcoma.
12459838 - Pine resin and biopin ointment: effects of water-soluble fractions on cytokine producti...
50128 - Kinetics of both leukemic and normal cell population reduction following 5-azacytidine.
24784368 - Out-of-field organ doses and associated radiogenic risks from para-aortic radiotherapy ...
2791448 - Influence of a high-fat meal on the absorption of morphine from oral solutions.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-27
Journal Detail:
Title:  Hypertension research : official journal of the Japanese Society of Hypertension     Volume:  -     ISSN:  1348-4214     ISO Abbreviation:  Hypertens. Res.     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-9-27     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9307690     Medline TA:  Hypertens Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Clinical Research of Kanagawa Association of Medical and Dental Practitioners, Yokohama, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Intake of high sucrose during pregnancy altered large-conductance Ca(2+)-activated K(+) channels and...
Next Document:  Bronchial asthma and COPD due to irritants in the workplace - an evidence-based approach.